These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 7130629)

  • 1. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
    Niessen F; Campinchi R; Bloch-Michel E
    J Fr Ophtalmol; 1982; 5(6-7):407-16. PubMed ID: 7130629
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical observation of 85 patients with Behçet's uveitis treated with immunosuppressive agents combined with steroids].
    Zhao M; Wang H; Jiao X; Wei WB
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):202-6. PubMed ID: 23866699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive therapy of Behcet's syndrome. Long term follow-up evaluation (author's transl)].
    Bonnet M
    J Fr Ophtalmol; 1981; 4(6-7):455-64. PubMed ID: 7299062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular prognosis in Behçet's disease].
    Cochereau-Massin I; Wechsler B; Le Hoang P; Le Thi Huong Du; Girard B; Rousselie F; Godeau P
    J Fr Ophtalmol; 1992; 15(5):343-7. PubMed ID: 1430813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.
    Zaghetto JM; Yamamoto MM; Souza MB; Silva FT; Hirata CE; Olivalves E; Yamamoto JH
    Arq Bras Oftalmol; 2010; 73(1):40-6. PubMed ID: 20464112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.
    Kramer M; Amer R; Mukamel M; Snir M; Jaouni T; Friling R
    Eye (Lond); 2009 Nov; 23(11):2034-41. PubMed ID: 19151650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behçet's disease and immunosuppressive treatment. Our personal experience.
    Bietti GB; Cerulli L; Pivetti-Pezzi P
    Mod Probl Ophthalmol; 1976; 16():314-23. PubMed ID: 55960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine in severe uveitis of Behçet's disease.
    Saadoun D; Wechsler B; Terrada C; Hajage D; Le Thi Huong D; Resche-Rigon M; Cassoux N; Le Hoang P; Amoura Z; Bodaghi B; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1733-8. PubMed ID: 20665749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveitis in Behçet disease: an analysis of 880 patients.
    Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
    Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term chlorambucil for refractory uveitis in Behcet's disease.
    Mudun BA; Ergen A; Ipcioglu SU; Burumcek EY; Durlu Y; Arslan MO
    Ocul Immunol Inflamm; 2001 Dec; 9(4):219-29. PubMed ID: 11935432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
    Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
    Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive treatment of Behçet's disease (author's transl)].
    Eichholtz W; Konen W; Mies R; Lang R
    Klin Monbl Augenheilkd; 1977 Oct; 171(4):627-31. PubMed ID: 592657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveitis associated with pediatric behçet disease in the american midwest.
    Kesen MR; Goldstein DA; Tessler HH
    Am J Ophthalmol; 2008 Dec; 146(6):819-27.e2. PubMed ID: 18672222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive agents and Behçet's syndrome: critical analysis of results].
    Bonamour G; Bonnet M
    Adv Ophthalmol; 1978; 36():118-29. PubMed ID: 665399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study.
    Gül A; Tugal-Tutkun I; Dinarello CA; Reznikov L; Esen BA; Mirza A; Scannon P; Solinger A
    Ann Rheum Dis; 2012 Apr; 71(4):563-6. PubMed ID: 22084392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behçet's disease: clinical and immunological response to immunosuppressive therapy. A case report.
    Rimon D; Lahat N; Nir E; Cohen L
    Isr J Med Sci; 1985 Jan; 21(1):57-61. PubMed ID: 3156102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behçet's disease: a study of 20 cases].
    Jacobs K; Vrijghem JC; Linsen C; Leys A
    Bull Soc Belge Ophtalmol; 1989; 230():85-93. PubMed ID: 2488438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.